Pharmaceuticals, Biotechnology and Life Sciences
Saint-Beauzire Facility Saint-Beauzire Production Line for both liquid and lyophilized forms BUBENDORF, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) — Switzerland-based…
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative…
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing…
Annual Report 2024Regulated information 22 March 2025 The board of directors of Financière de Tubize has established the 2024 annual…
AURORA, Colo., March 22, 2025 (GLOBE NEWSWIRE) — Arialief is a unique nerve pain and discomfort relief supplement with natural…
Company Announcement AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle)Genmab…
No Shareholder Action is Required at this TimeBOSTON, March 21, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea…
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)…
ZUG, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — The attached notifications relate to trades entered into by a PDMR of…
Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes…